Great Lakes Advisors, LLC Neurocrine Biosciences Inc Transaction History

Great Lakes Advisors, LLC

$11.1 Billion
Q3 2024

A detailed history of Great Lakes Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 10,407 shares of NBIX stock, worth $1.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,407

Previous 111,278 90.65%

Holding current value

$1.28 Million

Previous $15.3 Million 92.18%

% of portfolio

0.01%

Previous 0.14%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$114.58 - $153.15 $11.6 Million - $15.4 Million	-100,871 Reduced 90.65%	10,407 $1.2 Million
Q2 2024 Aug 05, 2024	SELL	$130.86 - $143.19 $567,801 - $621,301	-4,339 Reduced 3.75%	111,278 $15.3 Million
Q1 2024 May 08, 2024	SELL	$130.4 - $143.74 $6.24 Million - $6.88 Million	-47,868 Reduced 29.28%	115,617 $15.9 Million
Q4 2023 Feb 08, 2024	BUY	$106.07 - $132.76 $162,074 - $202,857	1,528 Added 0.94%	163,485 $21.5 Million
Q3 2023 Nov 07, 2023	BUY	$94.02 - $117.1 $11.4 Million - $14.2 Million	121,592 Added 301.23%	161,957 $18.2 Million
Q2 2023 Aug 10, 2023	SELL	$89.53 - $104.87 $3.88 Million - $4.55 Million	-43,349 Reduced 51.78%	40,365 $3.81 Million
Q1 2023 May 10, 2023	BUY	$94.11 - $123.02 $3.9 Million - $5.1 Million	41,488 Added 98.25%	83,714 $8.47 Million
Q4 2022 Feb 09, 2023	SELL	$106.72 - $127.06 $93,700 - $111,558	-878 Reduced 2.04%	42,226 $5.04 Million
Q3 2022 Nov 09, 2022	BUY	$92.03 - $107.81 $3.97 Million - $4.65 Million	43,104 New	43,104 $4.58 Million
Q4 2018 Feb 13, 2019	SELL	$68.32 - $124.36 $5.15 Million - $9.38 Million	-75,389 Closed	0 $0
Q3 2018 Nov 30, 2018	BUY	$98.88 - $125.85 $7.45 Million - $9.49 Million	75,389 New	75,389 $9.27 Million

Others Institutions Holding NBIX

# of Institutions

624

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.8B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Account

Great Lakes Advisors, LLC Neurocrine Biosciences Inc Transaction History